HALOZYME THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential · last filed 2026-02-17
- HALOZYME THERAPEUTICS, INC. effective income tax rate reconciliation, foreign income tax rate differential, amount for fiscal 2025 was $137.00K, a 9.27% decline from fiscal 2024.
- HALOZYME THERAPEUTICS, INC. effective income tax rate reconciliation, foreign income tax rate differential, amount for fiscal 2024 was $151.00K, a 43.81% increase from fiscal 2023.
- HALOZYME THERAPEUTICS, INC. effective income tax rate reconciliation, foreign income tax rate differential, amount for fiscal 2023 was $105.00K.
- HALOZYME THERAPEUTICS, INC. effective income tax rate reconciliation, foreign income tax rate differential, amount for fiscal 2021 was -$94.00K, a 139.66% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount 12 month |
|---|---|
| 2025-12-31 | $137.00K 10-K · filed 2026-02-17 |
| 2024-12-31 | $151.00K 10-K · filed 2026-02-17 |
| 2023-12-31 | $105.00K 10-K · filed 2026-02-17 |
| 2021-12-31 | -$94.00K 10-K · filed 2022-02-22 |
| 2020-12-31 | $237.00K 10-K · filed 2022-02-22 |
| 2019-12-31 | $318.00K 10-K · filed 2022-02-22 |
| 2018-12-31 | $7.11M 10-K · filed 2021-02-23 |
| 2017-12-31 | $33.67M 10-K · filed 2020-02-24 |
| 2016-12-31 | $36.80M 10-K · filed 2019-02-21 |
| 2015-12-31 | $14.95M 10-K · filed 2018-02-20 |
| 2014-12-31 | $12.75M 10-K · filed 2017-02-28 |
| 2013-12-31 | $0.00 10-K · filed 2016-02-29 |
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 |